# The efficacy of the novel “wall pierce” technique for common femoral access in endovascular therapy

**Authors:** Shinsuke Mori, Norihiro Kobayashi, Masakazu Tsutsumi, Yoshiaki Ito

PMC · DOI: 10.1002/ccr3.9233 · Clinical Case Reports · 2024-07-31

## TL;DR

A new technique called 'wall PIERCE' helps with difficult artery access during endovascular therapy, successfully used in two cases without complications.

## Contribution

The 'wall PIERCE' technique is introduced as a novel method for challenging sheath insertion in endovascular therapy.

## Key findings

- The 'wall PIERCE' technique successfully facilitated sheath insertion in two challenging cases.
- No complications were observed in the cases where the technique was applied.

## Abstract

Under challenging common femoral artery access scenarios, the “wall PIERCE” technique, which utilizes a larger puncture needle to pierce the vessel wall along the guidewire, facilitates sheath insertion. This method proved successful in two cases without any complications, presenting a valuable addition to strategies for addressing challenging sheath insertion scenarios.

## Full-text entities

- **Diseases:** diabetes mellitus (MESH:D003920), hematoma (MESH:D006406), pain (MESH:D010146), calcified (MESH:D018333), CFA (MESH:D002340), total occlusion of the (MESH:D001157), femoral artery (MESH:D005266), lower-extremity artery disease (MESH:D002539), calcification (MESH:D002114), ischemia (MESH:D007511), ischemic ulcer (MESH:D014456), gangrene (MESH:D005734), EVT (MESH:D016609)
- **Chemicals:** 5Fr (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11291550/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11291550/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC11291550/full.md

---
Source: https://tomesphere.com/paper/PMC11291550